DXCM
DexCom IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$22.60B
P/E Ratio
26.26
EPS
$2.23
Beta
1.40
52W High
$89.98
52W Low
$54.11
50-Day MA
$63.72
200-Day MA
$68.45
Dividend Yield
—
Profit Margin
19.30%
Forward P/E
23.70
PEG Ratio
1.13
About DexCom Inc
DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has a manufacturing facility in Mesa, Arizona.
Fundamentals
| Revenue (TTM) | $4.82B |
| Gross Profit (TTM) | $2.96B |
| EBITDA | $1.29B |
| Operating Margin | 21.40% |
| Return on Equity | 35.60% |
| Return on Assets | 9.65% |
| Revenue/Share (TTM) | $12.39 |
| Book Value | $7.66 |
| Price-to-Book | 7.91 |
| Price-to-Sales (TTM) | 4.69 |
| EV/Revenue | 4.641 |
| EV/EBITDA | 15.11 |
| Quarterly Earnings Growth (YoY) | 92.20% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $385.87M |
| Float | $383.95M |
| % Insiders | 0.28% |
| % Institutions | 98.91% |
Historical Volatility
HV 10-Day
41.30%
HV 20-Day
39.56%
HV 30-Day
36.32%
HV 60-Day
33.23%
HV Rank
39.3%
Volatility is currently expanding
Analyst Ratings
Consensus ($83.28 target)
4
Strong Buy20
Buy2
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/14/2026